Uterine fibroids
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Clinically diagnosed with uterine fibroids based on symptoms and imaging (ultrasound or MRI), in accordance with FIGO classification and Chinese expert consensus; 2. Indicated for uterine fibroid surgery and planning to undergo total hysterectomy; 3. Receiving surgical treatment for uterine fibroids for the first time; 4. Aged between 35 and 55 years; 5. Able to understand the study content and voluntarily sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Preoperative assessment suspects or confirms malignant lesions of the cervix or endometrium; 2. Coexisting severe cardiovascular, liver, kidney, endocrine, or hematopoietic system diseases, considered surgical contraindications; 3. Received hormone therapy (e.g., GnRH agonists) within 3 months prior to the start of the study; 4. Coexisting active infectious diseases (e.g., tuberculosis, HIV, or syphilis); 5. Documented history of mental illness (e.g., schizophrenia, major depression) or cognitive impairment; 6. Simultaneously participating in other systematic psychotherapy or intervention programs; 7. Currently participating in other clinical intervention trials; 8. Pregnancy or breastfeeding period; 9. Other conditions that the researcher believes may compromise participant safety or data integrity.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Score of Self-Perceived Burden Scale (SPBS); | — |
Secondary
| Measure | Time frame |
|---|---|
| Psychological Status Scores (Anxiety, Depression, Self-esteem, Self-efficacy);Health-related Quality of Life (SF-36) Score;Physiological Stress Indicators (Serum Cortisol, HRV);Postoperative Recovery Indicators (Ambulation, LOS, VAS Pain Score, Complications);Patient Experience Indicators (Nursing Satisfaction, Treatment Compliance); | — |
Countries
China
Contacts
Yichang Central People's Hospital